Your browser doesn't support javascript.
loading
Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trial.
Klein, Oliver; Kee, Damien; Gao, Bo; Markman, Ben; da Gama Duarte, Jessica; Quigley, Luke; Jackett, Louise; Linklater, Richelle; Strickland, Andrew; Scott, Clare; Mileshkin, Linda; Palmer, Jodie; Carlino, Matteo; Behren, Andreas; Cebon, Jonathan.
Afiliação
  • Klein O; Department of Medical Oncology, Olivia Newton-John Cancer Centre, Austin Health, Melbourne, Victoria, Australia oliver.klein@onjcri.org.au.
  • Kee D; Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia.
  • Gao B; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Markman B; Blacktown Hospital and the University of Sydney, Sydney, New South Wales, Australia.
  • da Gama Duarte J; Department of Medical Oncology, Monash Health, Melbourne, Victoria, Australia.
  • Quigley L; Monash University, Melbourne, Victoria, Australia.
  • Jackett L; Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia.
  • Linklater R; School of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia.
  • Strickland A; Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia.
  • Scott C; School of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia.
  • Mileshkin L; Department of Anatomical Pathology, Austin Health, Melbourne, Victoria, Australia.
  • Palmer J; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Carlino M; Department of Medical Oncology, Monash Health, Melbourne, Victoria, Australia.
  • Behren A; Monash University, Melbourne, Victoria, Australia.
  • Cebon J; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
J Immunother Cancer ; 9(11)2021 11.
Article em En | MEDLINE | ID: mdl-34782426

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Ipilimumab / Nivolumabe / Neoplasias dos Genitais Femininos / Imunoterapia Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: J Immunother Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Ipilimumab / Nivolumabe / Neoplasias dos Genitais Femininos / Imunoterapia Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: J Immunother Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália